No more than 15 authors can be listed.Please ensure the authors are listed in the right order.If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.
Hypersensitivity pneumonitis (HP) is an immune-mediated interstitial lung disease caused by inhaled antigens.
Atopic dermatitis (AD) is characterized by skin barrier dysfunction and may facilitate epicutaneous sensitization to environmental antigens. We hypothesized that AD is associated with younger age at HP diagnosis.
We analyzed the JMDC claims database in Japan (2014-2023) and identified patients with HP. Age at first recorded HP diagnosis was compared between patients with and without AD. Subgroup analyses were performed by sex andasthma status. External validation was conducted using the TriNetX Global Collaborative Network, wherepropensity score matching for age and sex was used to compare HP risk in adults with and without AD.
In JMDC, 19,215 patients with HP were identified, including 440 (2.3%) with AD. Patients with AD were younger at first HP diagnosis than those without AD (65.4 years [SD 17.1] vs 70.1 years [SD 13.9], p<0.001). This association remained significant in men, women, and patients without asthma. Among patients in whom AD preceded HP, the difference also persisted (66.3 years [SD 18.4] vs 70.1 years [SD 13.9], p=0.010). In TriNetX, adult patients with AD had a higher risk of HP after propensity score matching than matched patients without AD (risk ratio 1.91, 95% confidence interval 1.612.27, p<0.0001). Among patients with HP, those with AD were also younger at diagnosis(62.2 years [SD 22.2] vs 68.6 years [SD 16.3], p<0.0001).
AD was associated with younger age at HP diagnosis in both Japanese and global datasets and with increased HP risk in the global validation cohort. Impaired skin barrier function and epicutaneous sensitization may contribute to earlier development of HP.